Biotron Ltd
ASX:BIT

Watchlist Manager
Biotron Ltd Logo
Biotron Ltd
ASX:BIT
Watchlist
Price: 0.003 AUD Market Closed
Market Cap: 4m AUD

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Biotron Ltd

Revenue
1.8m AUD
Cost of Revenue
-1.7m AUD
Gross Profit
72.7k AUD
Operating Expenses
-1.5m AUD
Operating Income
-1.4m AUD
Other Expenses
20.9k AUD
Net Income
-1.4m AUD

Margins Comparison
Biotron Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
AU
Biotron Ltd
ASX:BIT
4m AUD
4%
-79%
-78%
FR
Pharnext SCA
OTC:PNEXF
6T USD
0%
-17 527%
-21 040%
US
Abbvie Inc
NYSE:ABBV
346.1B USD
70%
29%
8%
US
Amgen Inc
NASDAQ:AMGN
150.4B USD
62%
22%
12%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
128.5B USD
86%
40%
-5%
US
Gilead Sciences Inc
NASDAQ:GILD
128.1B USD
78%
38%
2%
US
Epizyme Inc
F:EPE
94.1B EUR
76%
-370%
-392%
AU
CSL Ltd
ASX:CSL
121.3B AUD
52%
26%
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
66.2B USD
87%
30%
31%
US
Seagen Inc
F:SGT
39.3B EUR
75%
-33%
-33%
NL
argenx SE
XBRU:ARGX
35.3B EUR
90%
-1%
38%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Biotron Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Biotron Ltd
ASX:BIT
4m AUD
-122%
-82%
-123%
-186%
FR
Pharnext SCA
OTC:PNEXF
6T USD
115%
-391%
275%
3 093%
US
Abbvie Inc
NYSE:ABBV
346.1B USD
62%
3%
17%
20%
US
Amgen Inc
NASDAQ:AMGN
150.4B USD
68%
4%
10%
10%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
128.5B USD
-3%
-2%
23%
-102%
US
Gilead Sciences Inc
NASDAQ:GILD
128.1B USD
2%
1%
22%
15%
US
Epizyme Inc
F:EPE
94.1B EUR
-877%
-67%
-73%
-182%
AU
CSL Ltd
ASX:CSL
121.3B AUD
15%
7%
12%
9%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
66.2B USD
16%
12%
13%
65%
US
Seagen Inc
F:SGT
39.3B EUR
-28%
-21%
-27%
-39%
NL
argenx SE
XBRU:ARGX
35.3B EUR
17%
16%
0%
-4%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less